“…IV iron therapy in obstetrics and gynaecology is recommended in United Kingdom, Germany, Switzerland, Scandinavia, Spain, Eastern Europe, Russia, Pakistan, India, Malaysia, Singapore, Indonesia, China, Thailand, Peru, Argentina, Chile, Australia, and the United States 2,4,6,[10][11][12][13][14]22,40,[43][44][45][46][47][48][49][50][51] . IV iron therapy is considered when oral iron therapy fails or is expected to fail in the following clinical scenarios: oral iron therapy intolerance 2,4,6,[10][11][12][13][14]22,40,[43][44][45][46][47]49,50 , oral iron therapy unresponsiveness 2,4,6,[10][11][12][13][14]22,40,[43][44]…”